Z79.818 - Long term (current) use of other agents affecting estrogen receptors and estrogen levels
- Applicable to Long term (current) use of other agents affecting estrogen receptors and estrogen levels
- The 2025 edition of ICD10-CM Z79.818 became effective on October 1, 2024.
- This is the American ICD10-CM version of Z79.818 - other international versions of ICD10 Z79.818 may differ.
- Z79.818 is a Billable / Specific ICD10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
Inclusion terms help to clarify and specify the conditions or diseases covered by a particular ICD-10-CM code.
Inclusion Term:
- Long term (current) use of estrogen receptor downregulators
- Long term (current) use of fulvestrant (Faslodex)
- Long term (current) use of gonadotropin-releasing hormone (GnRH) agonist
- Long term (current) use of goserelin acetate (Zoladex)
- Long term (current) use of leuprolide acetate (leuprorelin) (Lupron)
- Long term (current) use of megestrol acetate (Megace)
Billable/Specific Code
The following codes above Z79.818 contain annotation back-references that may be applicable to Z79.818:
- Chapter: Z00-Z99 - Factors influencing health status and contact with health services
- Section: Z77-Z99 - Persons with potential health hazards related to family and personal history and certain conditions influencing health status
- Category: Z79 - Long term (current) drug therapy
Browse other similar CM codes:
Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.
Please, give attribution to our website icd10all.com